Clinical Trial Update: The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

View source ↗

Summary

Real-world data assess the effectiveness and safety of niraparib in Korean women with primary and recurrent epithelial ovarian cancer. The study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Drugs mentioned

• Zejula (Niraparib)

Snippet

Sponsor: Asan Medical Center | Conditions: Epithelial Ovarian Cancer | Status: COMPLETED